Here are five predictions for gen AI in healthcare in 2024

The Signify Research Generative AI Team and Signify Premium Insights Generative AI Editor, Alan Stoddart, have compiled their top five predictions for this year’s generative AI market.

1. Clinical workflow & patient engagement will be the standout early use cases of generative AI
Despite some of the hype and claims about the high-flying potential of generative AI in healthcare, in 2024 the tools that gain traction will be more grounded: patient engagement and clinical workflow.

2. Generative AI will enable doctors to focus on healthcare
Doctors offer their patients the greatest value when they are focused on clinical care, not administrative tasks. Gen AI will help free physicians from this burden, allowing their efforts to be directly expended on patients’ clinical care.

3. Tailored data offers a crucial competitive edge
Data will be one of the key differentiators between purveyors of gen AI solutions. Those who own data, who control access to data or facilitate the use of data therefore inhabit a lucrative space.

4. Competition will intensify. everywhere
The excitement around generative AI, and the potential for both patients and profits, means that competition will be intense. In some areas the barriers to entry are relatively low, here in particular, will vendor battles be especially fierce.

5. No software as a medical device will come to market in 2024
Gen AI’s potential in healthcare is great, but so too are the hurdles. One particularly significant obstacle for solutions to be used as medical devices is regulation. Generative AI’s novelty and nuance mean regulatory frameworks could be a long time in the making, stymieing the technology’s use for diagnosis and detection. Signify Research